GSK plc (ADR)
General ticker "GSK" information:
- Sector: Health Care
- Industry: Drug Manufacturers - General
- Capitalization: $78.8B (TTM average)
GSK plc (ADR) follows the US Stock Market performance with the rate: 45.8%.
Estimated limits based on current volatility of 1.4%: low 48.75$, high 50.12$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-11-14, amount 0.41$ (Y3.40%)
- Total employees count: 99451 as of 2013
Short-term GSK quotes
Long-term GSK plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | £29,324.00MM | £30,328.00MM | £31,376.00MM |
| Operating Expenses | £22,891.00MM | £23,583.00MM | £27,355.00MM |
| Operating Income | £6,433.00MM | £6,745.00MM | £4,021.00MM |
| Non-Operating Income | £-805.00MM | £-681.00MM | £-544.00MM |
| Interest Expense | £855.53MM | £775.00MM | £657.58MM |
| R&D Expense | £5,488.00MM | £6,223.00MM | £6,401.00MM |
| Income(Loss) | £5,628.00MM | £6,064.00MM | £3,477.00MM |
| Taxes | £707.00MM | £756.00MM | £526.00MM |
| Profit(Loss)* | £4,921.00MM | £4,928.00MM | £2,575.00MM |
| Stockholders Equity | £10,598.00MM | £17,014.76MM | £13,671.00MM |
| Inventory | £5,146.00MM | £7,008.85MM | £5,669.00MM |
| Assets | £60,146.00MM | £75,219.57MM | £59,463.00MM |
| Operating Cash Flow | £8,160.54MM | £7,890.89MM | £6,554.00MM |
| Capital expenditure | £1,407.92MM | £1,633.37MM | £2,982.00MM |
| Investing Cash Flow | £-10,881.55MM | £-2,404.06MM | £-1,229.00MM |
| Financing Cash Flow | £2,048.45MM | £-6,068.58MM | £-4,726.00MM |
| Earnings Per Share** | £2.44 | £2.43 | £1.26 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.